Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae

Clinical Microbiology and Infection

Volumn 22, Issue 7, 2016, Pages 646.e1-646.e4

  Bernard, J ^a   Armand Lefevre L ^a,b,c   Luce, E ^a   El Mniai, A ^a   Chau, F ^b,c   Casalino, E ^a   Andremont, A ^a,b,c   Ruppe E ^a,b,c  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antibiotic dosage; Antibiotic impact; Antibiotic resistance; Escherichia coli; Fluoroquinolones; Intestinal microbiota; Quantification

Indexed keywords

LEVOFLOXACIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FECES LEVEL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES; FEMALE; GENE MUTATION; GYRA GENE; HUMAN; INTESTINE FLORA; MALE; PARC GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; BACTERIAL LOAD; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; LEVOFLOXACIN; MALE;

EID: 84981271780     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.04.015     Document Type: Article

References (19)

1. [1] ECDC. European Surveillance of Antimicrobial Consumption Network (ESAC-Net) n.d. http://www.ecdc.europa.eu/en/activities/surveillance/esac-net/pages/index.aspx (accessed April 30, 2014).
2. [2] Dethlefsen, L., Huse, S., Sogin, M.L., Relman, D.A., The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol, 6, 2008, e280.
3. [3] Stewardson, A.J., Gaïa, N., François, P., Malhotra-Kumar, S., Delémont, C., Martinez de Tejada, B., et al. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, 21, 2015 344.e1–11.
4. [4] Taur, Y., Xavier, J.B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis Off Publ Infect Dis Soc Am 55 (2012), 905–914.
5. [5] Fantin, B., Duval, X., Massias, L., Alavoine, L., Chau, F., Retout, S., et al. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J Infect Dis 200 (2009), 390–398.
6. [6] de Lastours, V., Chau, F., Roy, C., Larroque, B., Fantin, B., Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone. J Antimicrob Chemother 69 (2014), 3393–3400.
7. [7] de Lastours, V., Cambau, E., Guillard, T., Marcade, G., Chau, F., Fantin, B., Diversity of individual dynamic patterns of emergence of resistance to quinolones in Escherichia coli from the fecal flora of healthy volunteers exposed to ciprofloxacin. J Infect Dis 206 (2012), 1399–1406.
8. [8] Nguyen, T.T., Guedj, J., Chachaty, E., de Gunzburg, J., Andremont, A., Mentré, F., Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted. PLoS Comput Biol, 10, 2014, e1003840.
9. [9] Ruppé, E., Lixandru, B., Cojocaru, R., Büke, C., Paramythiotou, E., Angebault, C., et al. Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women. Antimicrob Agents Chemother 57 (2013), 4512–4517.
10. [10] Edlund, C., Sjöstedt, S., Nord, C.E., Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora. Scand J Infect Dis 29 (1997), 383–386.
11. [11] Cavaco, L.M., Aarestrup, F.M., Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6’)Ib-cr, in Escherichia coli and Salmonella enterica and determinations of wild-type distributions. J Clin Microbiol 47 (2009), 2751–2758.
12. [12] Messer, J.W., Leslie, J.E., Houghtby, G.A., Peeler, J.T., Barnett, J.E., Bacillus stearothermophilus disc assay for detection of inhibitors in milk: collaborative study. J Assoc Off Anal Chem 65 (1982), 1208–1214.
13. [13] Courvalin, P., Leclercq, R., Rice, L.B., Antibiogramme. 3rd edn, 2010, ESKA and ASM Press, Washington DC.
14. [14] Guessennd, N., Bremont, S., Gbonon, V., Kacou-Ndouba, A., Ekaza, E., Lambert, T., et al. [Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast]. Pathol Biol (Paris) 56 (2008), 439–446.
15. [15] Ruimy, R., Genauzeau, E., Barnabe, C., Beaulieu, A., Tibayrenc, M., Andremont, A., Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect Immun 69 (2001), 584–588.
16. [16] Clermont, O., Dhanji, H., Upton, M., Gibreel, T., Fox, A., Boyd, D., et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64 (2009), 274–277.
17. [17] Rashid, M.-U., Weintraub, A., Nord, C.E., Development of antimicrobial resistance in the normal anaerobic microbiota during one year after administration of clindamycin or ciprofloxacin. Anaerobe 31 (2015), 72–77.
18. [18] Ruppé, E., Andremont, A., Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria. Front Microbiol, 4, 2013, 129.
19. [19] Moreno, E., Andreu, A., Pigrau, C., Kuskowski, M.A., Johnson, J.R., Prats, G., Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol 46 (2008), 2529–2534.